Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance
Source abstract
Abstract
Long-circulating nanoparticles are essential for increasing tumor accumulation to provide therapeutic efficacy. While it is known that tumor presence can alter the immune system, very few studies have explored this impact on nanoparticle circulation. In this report, we demonstrate how the presence of a tumor can change the local and global immune system, which dramatically increases particle clearance. We found that tumor presence significantly increased clearance of PRINT hydrogel nanoparticles from the circulation, resulting in increased accumulation in the liver and spleen, due to an increase in M2-like macrophages. Our findings highlight the need to better understand interactions between immune status and nanoparticle clearance, and suggest that further consideration of immune function is required for success in preclinical and clinical nanoparticle studies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immune cells in cancer · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695, United States
Funding
National Cancer Institute · NIH Office of the Director · National Institute of Allergy and Infectious Diseases · Defense Threat Reduction Agency · Liquidia Technologies
References (52)
Show source-provided references
1. 10.1146/annurev-med-040210-16254410.1146/annurev-med-040210-162544 ↗
2. 10.1007/BF0004952910.1007/BF00049529 ↗
3. 10.1038/nrc326110.1038/nrc3261 ↗
4. 10.1242/jcs.11639210.1242/jcs.116392 ↗
5. 10.1038/onc.2008.27110.1038/onc.2008.271 ↗
6. 10.1634/theoncologist.2012-027410.1634/theoncologist.2012-0274 ↗
7. 10.1242/dmm.00097610.1242/dmm.000976 ↗
8. 10.1038/nmat244210.1038/nmat2442 ↗
9. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
10. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
11. 10.1021/bm050260e10.1021/bm050260e ↗
12. 10.1007/s00262005058610.1007/s002620050586 ↗
13. 10.1007/BF0081226110.1007/BF00812261 ↗
14. 10.1097/00002371-200111000-0000110.1097/00002371-200111000-00001 ↗
15. 10.1007/s00262-002-0280-810.1007/s00262-002-0280-8 ↗
16. 10.1007/s00262-003-0443-210.1007/s00262-003-0443-2 ↗
17. 10.1172/JCI3142210.1172/JCI31422 ↗
18. 10.1172/JCI6689510.1172/JCI66895 ↗
19. 10.1039/b600913c10.1039/b600913c ↗
20. 10.1021/ja051977c10.1021/ja051977c ↗
21. 10.1021/la301279v10.1021/la301279v ↗
22. 10.1021/nl302638g10.1021/nl302638g ↗
23. 10.1073/pnas.101001310810.1073/pnas.1010013108 ↗
24. 10.1016/j.vascn.2010.01.00410.1016/j.vascn.2010.01.004 ↗
25. 10.1189/jlb.041320710.1189/jlb.0413207 ↗
26. 10.1016/S0731-7085(00)00377-010.1016/S0731-7085(00)00377-0 ↗
27. 10.1016/j.jconrel.2015.03.00110.1016/j.jconrel.2015.03.001 ↗
28. 10.1016/j.molonc.2013.02.01010.1016/j.molonc.2013.02.010 ↗
29. 10.1161/ATVBAHA.113.30016810.1161/ATVBAHA.113.300168 ↗
30. 10.1016/S1471-4906(02)02302-510.1016/S1471-4906(02)02302-5 ↗
31. 10.1038/nri317510.1038/nri3175 ↗
32. 10.1038/ni.269110.1038/ni.2691 ↗
33. 10.1097/00075198-200104000-0000810.1097/00075198-200104000-00008 ↗
34. 10.1056/NEJMra07273910.1056/NEJMra072739 ↗
35. 10.1182/blood-2005-09-377710.1182/blood-2005-09-3777 ↗
36. 10.1038/ni.193710.1038/ni.1937 ↗
37. 10.1124/jpet.113.20880110.1124/jpet.113.208801 ↗
38. 10.1016/j.nano.2015.05.00710.1016/j.nano.2015.05.007 ↗
39. 10.1371/journal.pone.009424110.1371/journal.pone.0094241 ↗
40. 10.1186/bcr319510.1186/bcr3195 ↗
41. 10.1152/ajplung.90485.200810.1152/ajplung.90485.2008 ↗
42. 10.1089/jir.2011.002010.1089/jir.2011.0020 ↗
43. 10.1152/physiolgenomics.00185.200710.1152/physiolgenomics.00185.2007 ↗
44. 10.1016/j.bbcan.2014.01.00410.1016/j.bbcan.2014.01.004 ↗
45. 10.1016/S0032-3861(97)00039-610.1016/S0032-3861(97)00039-6 ↗
46. 10.1016/j.nano.2014.03.01610.1016/j.nano.2014.03.016 ↗
47. 10.1097/CMR.0b013e328336ee1710.1097/CMR.0b013e328336ee17 ↗
48. 10.1101/pdb.prot508010.1101/pdb.prot5080 ↗
49. 10.1021/la902992w10.1021/la902992w ↗
50. 10.1016/j.cmpb.2010.01.00710.1016/j.cmpb.2010.01.007 ↗
51. 10.1109/TAC.1974.110070510.1109/TAC.1974.1100705 ↗
52. 10.1038/ni0706-68110.1038/ni0706-681 ↗